The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Next-generation characterization of the Cancer Cell Line Encyclopedia
Open accessAbstract
Large panels of comprehensively characterized human cancer models, including the Cancer Cell Line Encyclopedia (CCLE), have provided a rigorous framework with which to study genetic variants, candidate targets, and small-molecule and biological therapeutics and to identify new marker-driven cancer dependencies. To improve our understanding of the molecular features that contribute to cancer phenotypes, including drug responses, here we have expanded the characterizations of cancer cell lines to include genetic, RNA splicing, DNA methylation, histone H3 modification, microRNA expression and reverse-phase protein array data for 1,072 cell lines from individuals of various lineages and ethnicities. Integration of these data with functional characterizations such as drug-sensitivity, short hairpin RNA knockdown and CRISPR–Cas9 knockout data reveals potential targets for cancer drugs and associated biomarkers. Together, this dataset and an accompanying public data portal provide a resource for the acceleration of cancer research using model cancer cell lines. The original Cancer Cell Line Encyclopedia (CCLE) is expanded with deeper characterization of over 1,000 cell lines, including genomic, transcriptomic, and proteomic data, and integration with drug-sensitivity and gene-dependency data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Through systematic mining of databases for correlations between the cytotoxicity of 4,518 clinical and pre-clinical small molecules and E3 ligase expression levels across hundreds of human cancer cell lines,3–5 we identified CR8, a cyclin-dependent kinase (CDK) inhibitor,6 as a compound that acts as a molecular glue degrader.”
From The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K (2020) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
(2008) · Journal of Machine Learning Research · Cited by 33,051
Regularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
STRING v10: protein–protein interaction networks, integrated over the tree of life
Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Cepas, J., Simonovic, M., Roth, A., Santos, A., Tsafou, K. P., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1003 · Cited by 10,436
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
Self-citationAnalysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Self-citation
Cited by
Sorted by citations
Ferroptosis at the intersection of lipid metabolism and cellular signaling
Liang, D., Minikes, A. M., & Jiang, X. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.03.022 · Cited by 1,411
Quantitative Proteomics of the Cancer Cell Line Encyclopedia
Nusinow, D. P., Szpyt, J., Ghandi, M., Rose, C. M., McDonald, E. R., Kalocsay, M., Jané-Valbuena, J., Gelfand, E., Schweppe, D. K., Jedrychowski, M., et al. (2020) · Cell · doi:10.1016/j.cell.2019.12.023 · Cited by 957
Self-citationDiscovering the anticancer potential of non-oncology drugs by systematic viability profiling
Corsello, S. M., Nagari, R. T., Spangler, R. D., Rossen, J., Kocak, M., Bryan, J. G., Humeidi, R., Peck, D., Wu, X., Tang, A. A., et al. (2020) · Nature Cancer · doi:10.1038/s43018-019-0018-6 · Cited by 878
Self-citationHe, S., Bhatt, R., Brown, C., Brown, E. A., Buhr, D. L., Chantranuvatana, K., Danaher, P., Dunaway, D., Garrison, R. G., Geiss, G., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01483-z · Cited by 814
Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis
Zou, Y., Li, H., Graham, E. T., Deik, A., Eaton, J. K., Wang, W., Sandoval-Gomez, G., Clish, C. B., Doench, J. G., & Schreiber, S. L. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0472-6 · Cited by 753
Self-citationThe Complex Interplay between Antioxidants and ROS in Cancer
Harris, I. S., & DeNicola, G. M. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.03.002 · Cited by 659
Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer
Raghavan, S., Winter, P. S., Navia, A. W., Williams, H. L., DenAdel, A., Lowder, K. E., Galvez-Reyes, J., Kalekar, R. L., Mulugeta, N., Kapner, K. S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.11.017 · Cited by 592
Self-citationProteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy
Krug, K., Jaehnig, E. J., Satpathy, S., Blumenberg, L. M., Karpova, A. Y., Anurag, M., Miles, G., Mertins, P., Geffen, Y., Tang, L. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.036 · Cited by 553
Self-citationThe present and future of the Cancer Dependency Map
Arafeh, R., Shibue, T., Dempster, J. M., Hahn, W. C., & Vazquez, F. (2025) · Nature Reviews Cancer · doi:10.1038/s41568-024-00763-x · Cited by 454
“…datasets from three different efforts to characterize panels of cancer cell lines through omics profiling (Cancer Cell Line Encyclopedia (CCLE)) 4,5 , drug screening (profiling relative inhibition simultaneously in mixtures (PRISM)) 6–8 and genetic perturbations (Project Achilles) 9,10 to…”
Self-citationThe landscape of cancer cell line metabolism
Li, H., Ning, S., Ghandi, M., Kryukov, G. V., Gopal, S., Deik, A., Souza, A., Pierce, K. A., Keskula, P., Hernandez, D., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0404-8 · Cited by 511
Self-citationZhou, N., Yuan, X., Du, Q., Zhang, Z., Shi, X., Bao, J., Ning, Y., & Peng, L. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac935 · Cited by 514
The evolving metabolic landscape of chromatin biology and epigenetics
Dai, Z., Ramesh, V., & Locasale, J. W. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-020-0270-8 · Cited by 508
Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity
Kinker, G. S., Greenwald, A. C., Tal, R., Orlova, Z., Cuoco, M. S., McFarland, J. M., Warren, A., Rodman, C., Roth, J. A., Bender, S. A., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-00726-6 · Cited by 445
Self-citationGong, Y., Ji, P., Yang, Y., Xie, S., Yu, T., Xiao, Y., Jin, M., Ma, D., Guo, L., Pei, Y., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.012 · Cited by 486
Necroptosis and tumor progression
Yan, J., Wan, P., Choksi, S., & Liu, Z.-G. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.09.003 · Cited by 457
Robinson, J. L., Kocabaş, P., Wang, H., Cholley, P.-E., Cook, D., Nilsson, A., Anton, M., Ferreira, R., Domenzain, I., Billa, V., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aaz1482 · Cited by 442
A metastasis map of human cancer cell lines
Jin, X., Demere, Z., Nair, K., Ali, A., Ferraro, G. B., Natoli, T. E., Deik, A., Petronio, L., Tang, A. A., Zhu, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2969-2 · Cited by 436
Self-citationThe CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K
Słabicki, M., Kozicka, Z., Petzold, G., Li, Y.-D., Manojkumar, M., Bunker, R. D., Donovan, K. A., Sievers, Q. L., Koeppel, J., Suchyta, D., et al. (2020) · Nature · doi:10.1038/s41586-020-2374-x · Cited by 433
Self-citationChen, Y.-J., Roumeliotis, T. I., Chang, Y.-H., Chen, C.-T., Han, C.-L., Lin, M.-H., Chen, H.-W., Chang, G.-C., Chang, Y.-L., Wu, C.-T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.012 · Cited by 382
Bender, A., & Cortés-Ciriano, I. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.12.009 · Cited by 405
Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies
Centore, R. C., Sandoval, G. J., Soares, L. M. M., Kadoch, C., & Chan, H. M. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.07.011 · Cited by 400
Molecular Glues for Targeted Protein Degradation: From Serendipity to Rational Discovery
Dong, G., Ding, Y., He, S., & Sheng, C. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00895 · Cited by 369
ecDNA hubs drive cooperative intermolecular oncogene expression
Hung, K. L., Yost, K. E., Xie, L., Shi, Q., Helmsauer, K., Luebeck, J., Schöpflin, R., Lange, J. T., González, R. C., Weiser, N. E., et al. (2021) · Nature · doi:10.1038/s41586-021-04116-8 · Cited by 364
Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis
Hanniford, D., Ulloa-Morales, A. J., Karz, A., Berzoti-Coelho, M. G., Moubarak, R. S., Sánchez‐Sendra, B., Kloetgen, A., Dávalos, V., Imig, J., Wu, P., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2019.12.007 · Cited by 348
Massively parallel assessment of human variants with base editor screens
Hanna, R. E., Hegde, M., Fagre, C. R., DeWeirdt, P. C., Sangree, A. K., Szegletes, Z., Griffith, A., Feeley, M. N., Sanson, K. R., Baidi, Y., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.012 · Cited by 316
Cancer Cell Lines Are Useful Model Systems for Medical Research
Mirabelli, P., Coppola, L., & Salvatore, M. (2019) · Cancers · doi:10.3390/cancers11081098 · Cited by 346
Machine learning for multi-omics data integration in cancer
Cai, Z., Poulos, R. C., Liu, J., & Zhong, Q. (2022) · iScience · doi:10.1016/j.isci.2022.103798 · Cited by 366
“20.0) by using a common CCLE dataset.”
MethodInfluentialHolland, C. H., Tanevski, J., Perales-Patón, J., Gleixner, J., Kumar, M. P., Mereu, E., Joughin, B. A., Stegle, O., Lauffenburger, D. A., Heyn, H., et al. (2020) · Genome Biology · doi:10.1186/s13059-020-1949-z · Cited by 323
Cai, Y., Zhang, Y., Loh, Y. P., Tng, J. Q., Lim, M. C., Cao, Z., Raju, A., Lieberman Aiden, E., Li, S., Manikandan, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-20940-y · Cited by 321
A non-canonical tricarboxylic acid cycle underlies cellular identity
Arnold, P. K., Jackson, B. T., Paras, K. I., Brunner, J. S., Hart, M. L., Newsom, O. J., Alibeckoff, S. P., Endress, J., Drill, E., Sullivan, L. B., et al. (2022) · Nature · doi:10.1038/s41586-022-04475-w · Cited by 304
Mitochondrial RNA modifications shape metabolic plasticity in metastasis
Delaunay, S., Pascual, G., Feng, B., Klann, K., Behm, M., Hotz‐Wagenblatt, A., Richter, K., Zaoui, K., Herpel, E., Münch, C., et al. (2022) · Nature · doi:10.1038/s41586-022-04898-5 · Cited by 304
Empowering biomedical discovery with AI agents
Gao, S., Fang, A., Huang, Y., Giunchiglia, V., Noori, A., Schwarz, J. R., Ektefaie, Y., Kondic, J., & Zitnik, M. (2024) · Cell · doi:10.1016/j.cell.2024.09.022 · Cited by 315
Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition
Cohen‐Sharir, Y., McFarland, J. M., Abdusamad, M., Marquis, C., Bernhard, S. V., Kazachkova, M., Tang, H., Ippolito, M. R., Laue, K., Zerbib, J., et al. (2021) · Nature · doi:10.1038/s41586-020-03114-6 · Cited by 283
Self-citationNeurons release serine to support mRNA translation in pancreatic cancer
Banh, R. S., Biancur, D. E., Yamamoto, K., Sohn, A. S. W., Walters, B., Kuljanin, M., Gikandi, A., Wang, H., Mancias, J. D., Schneider, R. J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.016 · Cited by 292
Tang, M., Xie, Q., Gimple, R. C., Zhong, Z., Tam, T., Tian, J., Kidwell, R. L., Wu, Q., Prager, B. C., Qiu, Z., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0338-1 · Cited by 311
Chen, Y., Yang, S., Tavormina, J., Tampe, D., Zeisberg, M., Wang, H., Mahadevan, K. K., Wu, C.-J., Sugimoto, H., Chang, C.-C., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.06.011 · Cited by 289
High-speed fluorescence image–enabled cell sorting
Schraivogel, D., Kuhn, T. M., Rauscher, B., Rodríguez‐Martínez, M., Paulsen, M. S., Owsley, K., Middlebrook, A. J., Tischer, C., Ramasz, B., Ordoñez‐Rueda, D., et al. (2022) · Science · doi:10.1126/science.abj3013 · Cited by 287
DNA Sensing in Mismatch Repair-Deficient Tumor Cells Is Essential for Anti-tumor Immunity
Lu, C., Guan, J., Lu, S., Jin, Q., Rousseau, B., Lu, T., Stephens, D., Zhang, H., Zhu, J., Yang, M., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.11.006 · Cited by 285
Overcoming challenges and dogmas to understand the functions of pseudogenes
Cheetham, S. W., Faulkner, G. J., & Dinger, M. E. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0196-1 · Cited by 294
Wang, Y., Xie, Z., Kutschera, E., Adams, J. I., Kadash-Edmondson, K. E., & Xing, Y. (2024) · Nature Protocols · doi:10.1038/s41596-023-00944-2 · Cited by 296
Yang, C. G., Huang, X., Yan, L., Chen, J., Lv, Y., & Dai, S. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa164 · Cited by 269
Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs
Hadi, K., Yao, X., Behr, J. M., Deshpande, A. S., Xanthopoulakis, C., Tian, H., Kudman, S., Rosiene, J. A., Darmofal, M., DeRose, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.006 · Cited by 249
Self-citationTranscriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer
Zhang, Z., Lee, J., Ruan, H., Ye, Y., Krakowiak, J., Hu, Q., Xiang, Y., Gong, J., Zhou, B., Wang, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12543-5 · Cited by 264
Self-citationDeep learning-based approaches for multi-omics data integration and analysis
Ballard, J. L., Wang, Z., Li, W., Shen, L., & Long, Q. (2024) · BioData Mining · doi:10.1186/s13040-024-00391-z · Cited by 301
Big data in basic and translational cancer research
Jiang, P., Sinha, S., Aldape, K., Hannenhalli, S., Sahinalp, C., & Ruppin, E. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00502-0 · Cited by 254
CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition
Gallo, D., Young, J. T. F., Fourtounis, J., Martino, G., Álvarez-Quilón, A., Bernier, C., Duffy, N. M., Papp, R., Roulston, A., Stocco, R., et al. (2022) · Nature · doi:10.1038/s41586-022-04638-9 · Cited by 246
Deep learning for drug response prediction in cancer
Baptista, D., Ferreira, P. G., & Rocha, M. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz171 · Cited by 243
Recent trends in cancer therapy: A review on the current state of gene delivery
Yahya, E. B., & Alqadhi, A. M. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119087 · Cited by 251
Chong, W., Shang, L., Liu, J., Fang, Z., Du, F., Wu, H., Yang, L., Wang, Z., Chen, Y., Jia, S., et al. (2020) · Theranostics · doi:10.7150/thno.52717 · Cited by 230
Pan-cancer proteomic map of 949 human cell lines
Gonçalves, E., Poulos, R. C., Cai, Z., Barthorpe, S., Manda, S. S., Lucas, N., Beck, A., Bucio-Noble, D., Dausmann, M., Hall, C., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.06.010 · Cited by 239
“To circumvent the limitations of using patient tissue samples for this type of approach, biomarkers of cancer vulnerabilities have been analyzed using cancer cell lines, together with deep molecular characterization, functional genetic and pharmacological screens (Ghandi et al., 2019; Iorio et al., 2016; Tsherniak et…”
BackgroundMethodMulti-omics data integration considerations and study design for biological systems and disease
Graw, S., Chappell, K., Washam, C. L., Gies, A. J., Bird, J. T., Robeson, M. S., & Byrum, S. D. (2020) · Molecular Omics · doi:10.1039/d0mo00041h · Cited by 231
Powley, I. R., Patel, M., Miles, G. J., Pringle, H., Howells, L. M., Thomas, A., Kettleborough, C. A., Bryans, J. S., Hammonds, T. R., MacFarlane, M., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0672-6 · Cited by 230
The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer
Vervoort, S. J., Welsh, S. A., Devlin, J. R., Barbieri, E., Knight, D. A., Offley, S. R., Bjelosevic, S., Costacurta, M., Todorovski, I., Kearney, C. J., et al. (2021) · Cell · doi:10.1016/j.cell.2021.04.022 · Cited by 211
Ubiquitin ligases: guardians of mammalian development
Walma, D. A. C., Chen, Z., Bullock, A. N., & Yamada, K. M. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00448-5 · Cited by 220
Synthetic Lethality in Cancer Therapeutics: The Next Generation
Setton, J. S., Zinda, M. J., Riaz, N., Durocher, D., Zimmermann, M., Koehler, M. T., Reis-Filho, J. S., & Powell, S. N. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1503 · Cited by 214
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
Wasko, U. N., Jiang, J., Dalton, T. C., Curiel-Garcia, A., Edwards, A. C., Wang, Y., Lee, B., Orlen, M., Tian, S., Stalnecker, C. A., et al. (2024) · Nature · doi:10.1038/s41586-024-07379-z · Cited by 209
“Gene mutation, gene expression and lineage data were downloaded from the 22Q4 release of the DepMap Data Portal 45 .”
MethodArtificial Intelligence (AI)-Based Systems Biology Approaches in Multi-Omics Data Analysis of Cancer
Biswas, N., & Chakrabarti, S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.588221 · Cited by 226
Luna, A., Elloumi, F., Varma, S., Wang, Y., Rajapakse, V. N., Aladjem, M. I., Robert, J., Sander, C., Pommier, Y. G., & Reinhold, W. C. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa968 · Cited by 212
Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors
Roudko, V., Bozkus, C. C., Orfanelli, T., McClain, C. B., Carr, C. E., O’Donnell, T. J., Chakraborty, L., Samstein, R. M., Huang, K., Blank, S. V., et al. (2020) · Cell · doi:10.1016/j.cell.2020.11.004 · Cited by 219
Repeat expansions confer WRN dependence in microsatellite-unstable cancers
van Wietmarschen, N., Sridharan, S., Nathan, W. J., Tubbs, A., Chan, E. M., Callén, E., Wu, W., Belinky, F., Tripathi, V., Wong, N., et al. (2020) · Nature · doi:10.1038/s41586-020-2769-8 · Cited by 209
Massively parallel pooled screening reveals genomic determinants of nanoparticle delivery
Boehnke, N., Straehla, J. P., Safford, H. C., Kocak, M., Rees, M. G., Ronan, M. M., Rosenberg, D., Adelmann, C. H., Chivukula, R. R., Nabar, N., et al. (2022) · Science · doi:10.1126/science.abm5551 · Cited by 204
“EGFR-targeting compounds identified relevant biomarkers with high confidence Using univariate analysis for all CCLE features, we identified EGFR gene expression and protein abundance as the two most significantly correlated hits (q = 4 × 10−100 and q = 4 × 10−76, respectively) with antibody to EGFR, but much less sign…”
MethodInfluentialSelf-citationGenomic–transcriptomic evolution in lung cancer and metastasis
Martínez‐Ruiz, C., Black, J. R., Puttick, C., Hill, M. S., Demeulemeester, J., Cadieux, E. L., Thol, K., Jones, T. P., Veeriah, S., Naceur‐Lombardelli, C., et al. (2023) · Nature · doi:10.1038/s41586-023-05706-4 · Cited by 211
Reexamining assumptions about miRNA-guided gene silencing
Kilikevicius, A., Meister, G., & Corey, D. R. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1256 · Cited by 194
“A recent study of over 1000 cell lines (100) reported that HCT116 cells expressed miRNAs at levels that are typical.”
Zhao, W., Zhang, S., Zhu, Y., Xi, X., Bao, P., Ma, Z.-Y., Kapral, T. H., Chen, S., Žagrović, B., Yang, Y., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab702 · Cited by 211
Landscape of helper and regulatory antitumour CD4+ T cells in melanoma
Oliveira, G., Stromhaug, K., Cieri, N., Iorgulescu, J. B., Klaeger, S., Wolff, J. O., Rachimi, S., Chea, V. A., Krause, K., Freeman, S. S., et al. (2022) · Nature · doi:10.1038/s41586-022-04682-5 · Cited by 205
PDXNET Consortium, Woo, X. Y., EurOPDX Consortium, Giordano, J., Srivastava, A., Zhao, Z.-M., Lloyd, M. W., de Bruijn, R., Suh, Y.-S., Patidar, R., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00750-6 · Cited by 190
Self-citationA single-cell analysis of breast cancer cell lines to study tumour heterogeneity and drug response
Gambardella, G., Viscido, G., Tumaini, B., Isacchi, A., Bosotti, R., & di Bernardo, D. (2022) · Nature Communications · doi:10.1038/s41467-022-29358-6 · Cited by 204
McFarland, J. M., Paolella, B. R., Warren, A., Geiger-Schuller, K., Shibue, T., Rothberg, M., Kuksenko, O., Colgan, W. N., Jones, A., Chambers, E., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17440-w · Cited by 173
Self-citationExpanding control of the tumor cell cycle with a CDK2/4/6 inhibitor
Freeman‐Cook, K. D., Hoffman, R. L., Miller, N. L. G., Almaden, J., Chionis, J., Zhang, Q., Eisele, K. J., Liu, C., Zhang, C., Huser, N. H., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.08.009 · Cited by 195
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
Nabet, B. Y., Hamidi, H., Lee, M. C., Banchereau, R., Morris, S., Adler, L., Gayevskiy, V., Elhossiny, A. M., Srivastava, M. K., Patil, N. S., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.01.010 · Cited by 196
Immunogenomic Landscape of Hematological Malignancies
Dufva, O., Pölönen, P., Brück, O. E., Keränen, M. A. I., Klievink, J., Mehtonen, J., Huuhtanen, J., Kumar, A., Malani, D., Siitonen, S. M., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.002 · Cited by 194
A unified model for the G1/S cell cycle transition
Hume, S., Dianov, G. L., & Ramadan, K. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1002 · Cited by 207
Pan-cancer analysis identifies tumor-specific antigens derived from transposable elements
Shah, N. M., Jang, H. J., Liang, Y., Maeng, J. H., Tzeng, S.-C., Wu, A., Basri, N. L., Qu, X., Fan, C., Li, A., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01349-3 · Cited by 175
Aneuploidy-Driven Genome Instability Triggers Resistance to Chemotherapy
Ippolito, M. R., Martis, V., Martin, S., Tijhuis, A. E., Hong, C., Wardenaar, R., Dumont, M., Zerbib, J., Spierings, D. C. J., Fachinetti, D., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2021.07.006 · Cited by 192
Targeting pan-essential genes in cancer: Challenges and opportunities
Chang, L., Ruiz, P. A., Ito, T., & Sellers, W. R. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.12.008 · Cited by 188
Self-citationRecent advances in the developmental origin of neuroblastoma: an overview
Ponzoni, M., Bachetti, T., Corrias, M. V., Brignole, C., Pastorino, F., Calarco, E., Bensa, V., Giusto, E., Ceccherini, I., & Perri, P. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02281-w · Cited by 193
“Knockdown profiles of 17 NB cell lines were compared with the profiles of 546 other cancer cells [109] to identify subtype-independent essential genes.”
ResultACSL4 and polyunsaturated lipids support metastatic extravasation and colonization
Wang, Y., Hu, M., Cao, J., Wang, F., Han, J. R., Wu, T. W., Li, L., Yu, J., Fan, Y., Xie, G., et al. (2024) · Cell · doi:10.1016/j.cell.2024.10.047 · Cited by 197
Wu, Y., & Xie, L. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.12.030 · Cited by 220
Bruno, P. M., Lu, M., Dennis, K. A., Inam, H., Moore, C. J., Sheehe, J., Elledge, S. J., Hemann, M. T., & Pritchard, J. R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921649117 · Cited by 175
From Donor to the Lab: A Fascinating Journey of Primary Cell Lines
Richter, M., Piwocka, O., Musielak, M., Piotrowski, I., Suchorska, W. M., & Trzeciak, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.711381 · Cited by 174
Zhang, P., Gao, D., An, K., Shen, Q., Wang, C., Zhang, Y., Pan, X., Chen, X., Lyv, Y., Cui, C., et al. (2020) · Nature Chemistry · doi:10.1038/s41557-020-0426-3 · Cited by 183
Ma, J., Fong, S. H., Luo, Y., Bakkenist, C. J., Shen, J. P., Mourragui, S., Wessels, L. F. A., Hafner, M., Sharan, R., Peng, J., et al. (2021) · Nature Cancer · doi:10.1038/s43018-020-00169-2 · Cited by 180
Undisclosed, unmet and neglected challenges in multi-omics studies
Tarazona, S., Arzalluz-Luque, Á., & Conesa, A. (2021) · Nature Computational Science · doi:10.1038/s43588-021-00086-z · Cited by 185
Jin, H., Zhang, C., Zwahlen, M., von Feilitzen, K., Karlsson, M., Shi, M., Yuan, M., Song, X., Li, X., Yang, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41132-w · Cited by 188
Santana-Codina, N., del Rey, M. Q., Kapner, K. S., Zhang, H., Gikandi, A., Malcolm, C., Poupault, C. L., Kuljanin, M., John, K. M., Biancur, D. E., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0043 · Cited by 182
“Across multiple additional PDAC cell lines, we noted variability in the degree of proliferative block following NCOA4 depletion, as predicted by dependency scores in DepMap (Fig.”
InfluentialEP300 Selectively Controls the Enhancer Landscape of MYCN -Amplified Neuroblastoma
Durbin, A. D., Wang, T., Wimalasena, V. K., Zimmerman, M. W., Li, D., Dharia, N. V., Mariani, L., Shendy, N. A. M., Nance, S., Patel, A. G., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0385 · Cited by 181
“CCLE analyses of RNA expression and proteomic expression were performed using the 20Q1 data release (67, 68).”
Comprehensive characterization of circular RNAs in ~ 1000 human cancer cell lines
Ruan, H., Xiang, Y., Ko, J., Li, S., Jing, Y., Zhu, X., Ye, Y., Zhang, Z., Mills, T., Feng, J. Q., et al. (2019) · Genome Medicine · doi:10.1186/s13073-019-0663-5 · Cited by 169
Self-citationRewiring cancer drivers to activate apoptosis
Gourisankar, S. P., Krokhotin, A., Ji, W., Liu, X., Chang, C.-Y., Kim, S. H., Li, Z., Wenderski, W., Simanauskaite, J., Yang, H., et al. (2023) · Nature · doi:10.1038/s41586-023-06348-2 · Cited by 174
New insights into abasic site repair and tolerance
Thompson, P. S., & Cortez, D. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102866 · Cited by 172
A first-generation pediatric cancer dependency map
Dharia, N. V., Kugener, G., Guenther, L. M., Malone, C. F., Durbin, A. D., Hong, A. L., Howard, T. P., Bandopadhayay, P., Wechsler, C. S., Fung, I., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00819-w · Cited by 153
Self-citationMUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer
Yasumizu, Y., Rajabi, H. N., Jin, C., Hata, T., Pitroda, S. P., Long, M. D., Hagiwara, M., Li, W., Hu, Q., Liu, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14219-6 · Cited by 167
Proteome-wide mapping of short-lived proteins in human cells
Li, J., Cai, Z., Vaites, L. P., Shen, N., Mitchell, D. C., Huttlin, E. L., Paulo, J. A., Harry, B. L., & Gygi, S. P. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.09.015 · Cited by 159
Looking beyond the hype: applied AI and machine learning in translational medicine
Toh, T. S., Dondelinger, F., & Wang, D. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.027 · Cited by 159
Chapeau, E. A., Sansregret, L., Galli, G. G., Chêne, P., Wartmann, M., Mourikis, T. P., Jaaks, P., Baltschukat, S., Barbosa, I. A. M., Bauer, D., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00754-9 · Cited by 168
“Cells were maintained at 37 °C with 5% CO 2 . mRNA expression and DNA alteration data from in vitro cultures were previously generated 56 .”
Fibroblasts Fuel Immune Escape in the Tumor Microenvironment
Jaeghere, E. A. D., Denys, H. G., & Wever, O. D. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.09.009 · Cited by 163
Yang, C. G., Zhang, H., Chen, M., Wang, S., Qian, R., Zhang, L., Huang, X., Wang, J., Liu, Z., Qin, W., et al. (2022) · eLife · doi:10.7554/elife.71880 · Cited by 161
“The basal expression data of LINCS cell lines was achieved from the Cancer Cell Line Encyclopedia (CCLE) project (https://portals.broadinstitute.org/ccle/) ( Ghandi et al., 2019 ).”
NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer
Weiss‐Sadan, T., Ge, M., Hayashi, M., Gohar, M., Yao, C.-H., de Groot, A., Harry, S. A., Carlin, A. D., Fischer, H., Shi, L., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.01.012 · Cited by 159
Hicks, K. G., Cluntun, A. A., Schubert, H., Hackett, S. R., Berg, J. A., Leonard, P. G., Aleixo, M. A. A., Zhou, Y., Bott, A. J., Salvatore, S. R., et al. (2023) · Science · doi:10.1126/science.abm3452 · Cited by 171
Deshpande, A. S., Ulahannan, N., Pendleton, M., Dai, X., Ly, L., Behr, J. M., Schwenk, S., Liao, W., Augello, M. A., Tyer, C., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01289-z · Cited by 156
“%) expression tertiles in a database of cancer cell line gene expression 48 genome structure with substantially higher efficiency (70–80% of concatemers are high-order) than previous assays ( < 11%).”
BackgroundMethodSelf-citationLiao, H., Li, X., Zhao, L., Wang, Y., Wang, X., Wu, Y., Zhou, X., Fu, W., Liu, L., Hu, H.-G., et al. (2020) · Cell Discovery · doi:10.1038/s41421-020-0171-1 · Cited by 156
Metadata
- Authors
- Ghandi, M., Huang, F. W., Jané-Valbuena, J., Kryukov, G. V., Lo, C. C., McDonald, E. R., Barretina, J., Gelfand, E. T., Bielski, C. M., Li, H., Hu, K., Andreev-Drakhlin, A. Y., Kim, J., Hess, J. M., Haas, B. J., Aguet, F., Weir, B. A., Rothberg, M. V., Paolella, B. R., Lawrence, M. S., Akbani, R., Lu, Y., Tiv, H. L., Gokhale, P. C., de Weck, A., Mansour, A. A., Oh, C., Shih, J., Hadi, K., Rosen, Y., Bistline, J., Venkatesan, K., Reddy, A., Sonkin, D., Liu, M., Lehar, J., Korn, J. M., Porter, D. A., Jones, M. D., Golji, J., Caponigro, G., Taylor, J. E., Dunning, C. M., Creech, A. L., Warren, A. C., McFarland, J. M., Zamanighomi, M., Kauffmann, A., Stransky, N., Imielinski, M., Maruvka, Y. E., Cherniack, A. D., Tsherniak, A., Vazquez, F., Jaffe, J. D., Lane, A. A., Weinstock, D. M., Johannessen, C. M., Morrissey, M. P., Stegmeier, F., Schlegel, R., Hahn, W. C., Getz, G., Mills, G. B., Boehm, J. S., Golub, T. R., Garraway, L. A., & Sellers, W. R.
- Affiliations
- Broad Institute (US)
- The University of Texas MD Anderson Cancer Center (US)
- Cornell University (US)
- National Cancer Institute (US)
- Novartis Institutes for BioMedical Research (CH)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Sellers, William R.
- ORCID
- Ghandi, Mahmoud
- Huang, Franklin W.
- Kryukov, Gregory V.
- McDonald, E. Robert
- Barretina, Jordi
- Li, Haoxin
- Hu, Kevin
- Andreev-Drakhlin, Alexander Y.
- Kim, Jaegil
- Hess, Julian M.
- Haas, Brian J.
- Aguet, François
- Rothberg, Michael V.
- Paolella, Brenton R.
- Lawrence, Michael S.
- Akbani, Rehan
- Lu, Yiling
- Tiv, Hong L.
- Gokhale, Prafulla C.
- Oh, Coyin
- Shih, Juliann
- Hadi, Kevin
- Rosen, Yanay
- Venkatesan, Kavitha
- Reddy, Anupama
- Sonkin, Dmitriy
- Liu, Manway
- Korn, Joshua M.
- Jones, Michael D.
- Taylor, Jordan E.
- Creech, Amanda L.
- McFarland, James M.
- Zamanighomi, Mahdi
- Kauffmann, Audrey
- Stransky, Nicolas
- Imielinski, Marcin
- Maruvka, Yosef E.
- Cherniack, Andrew D.
- Tsherniak, Aviad
- Jaffe, Jacob D.
- Lane, Andrew A.
- Weinstock, David M.
- Johannessen, Cory M.
- Stegmeier, Frank
- Hahn, William C.
- Getz, Gad
- Mills, Gordon B.
- Boehm, Jesse S.
- Golub, Todd R.
- Garraway, Levi A.
- Sellers, William R.
- Venue
- Nature
- Published
- 2019-05
- Volume
- 569
- Issue
- 7757
- Pages
- 503-508
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6697103
- OpenAlex
- W2944727022
- Semantic Scholar
- b3631d8d2656c0c72ad92f3b0a77af2afde649a5
- Cited by
- 3,394
- References
- 67
- Citations by year
- 2026: 297 · 2025: 472 · 2024: 560 · 2023: 551 · 2022: 550 · 2021: 594 · 2020: 306 · 2019: 59
- FWCI
- 121.99
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- European Hematology Association (TRTH56)
- National Institutes of Health (5r21da025720-02)
- National Institute on Drug Abuse (R21-DA025720)
- National Cancer Institute (R50CA221675, P50CA217685, R01CA219943, P50CA098258, U24CA180922, U54CA224068, U24CA210949, U24CA210950, R50CA211461, R37CA225191, U01CA217842, U01CA176058, P30CA016672)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- Cancer Cell Line Encyclopedia, cancer cell lines, drug sensitivity, gene dependency, RNA splicing, DNA methylation, histone H3 modifications, microRNA expression, reverse phase protein array, CRISPR/Cas9 knockout, shRNA knockdown, therapeutic target, biomarkers, multi-omics integration, public data portals
- MeSH terms
- Gene Editing, Antineoplastic Agents, Ethnicity, Histones, Humans, Neoplasms, RNA Splicing, Biomarkers, Tumor, Drug Resistance, Neoplasm, DNA Methylation, MicroRNAs, Protein Array Analysis, Cell Line, Tumor, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
